In the News
PULMONX NAMES INDUSTRY VETERAN TO BOARD OF DIRECTORS
Pulmonx Names Industry Veteran to Board of Directors Redwood City,…
PULMONX ANNOUNCES THAT UNITEDHEALTHCARE, THE LARGEST COMMERCIAL INSURER IN THE UNITED STATES, HAS LIFTED COVERAGE RESTRICTIONS ON THE ZEPHYR VALVE, A MINIMALLY-INVASIVE TREATMENT OPTION FOR SEVERE EMPHYSEMA (COPD)
Both UnitedHealthcare® and EmblemHealth recently announced positive coverage…
THE NEW 2020 REPORT FROM THE GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD) GIVES HIGHEST EVIDENCE RATING TO ENDOBRONCHIAL VALVES, INCLUDING THE ZEPHYR VALVE, FOR TREATMENT OF EMPHYSEMA / COPD
GOLD’s evidence “A” rating affirms that endobronchial valves, like the Zephyr…
PULMONX ANNOUNCES THAT PRIORITY HEALTH NOW COVERS THE ZEPHYR VALVE, A LESS INVASIVE TREATMENT OPTION FOR SEVERE EMPHYSEMA (COPD)
PULMONX ANNOUNCES THAT PRIORITY HEALTH NOW COVERS THE ZEPHYR VALVE, A LESS…
PULMONX CLOSES $65 MILLION FINANCING AND ADDS CHIEF FINANCIAL OFFICER
PULMONX CLOSES $65 MILLION FINANCING AND ADDS CHIEF FINANCIAL OFFICER…
PULMONX ANNOUNCES THAT HUMANA HAS ISSUED A POSITIVE COVERAGE POLICY FOR THE ZEPHYR VALVE, A LESS INVASIVE TREATMENT OPTION FOR SEVERE EMPHYSEMA (COPD)
PULMONX ANNOUNCES THAT HUMANA HAS ISSUED A POSITIVE COVERAGE POLICY FOR THE…
HOUSTON METHODIST FIRST IN TEXAS, AND SECOND IN THE COUNTRY, TO OFFER NEW VALVE TREATMENT FOR EMPHYSEMA
HOUSTON METHODIST FIRST IN TEXAS, and SECOND IN THE COUNTRY, TO OFFER NEW…
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) ISSUES NEW GUIDELINES FOR COPD, RECOMMENDING SEVERE PATIENTS BE EVALUATED FOR BRONCHOSCOPIC LUNG VOLUME REDUCTION
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) ISSUES NEW GUIDELINES…
PULMONX ANNOUNCES THAT ONE OF THE LEADING HEALTH CARE PROVIDERS IN THE UNITED STATES NOW COVERS THE ZEPHYR VALVE FOR BRONCHSCOPIC LUNG VOLUME REDUCTION IN PATIENTS WITH SEVERE EMPHYSEMA
PULMONX ANNOUNCES THAT ONE OF THE LEADING HEALTH CARE PROVIDERS IN THE UNITED…
FDA APPROVES ZEPHYR ENDOBRONCHIAL VALVE FOR TREATING SEVERE EMPHYSEMA
FDA APPROVES ZEPHYR ENDOBRONCHIAL VALVE FOR TREATING SEVERE EMPHYSEMA First…